|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000000279 follistatin isoform 1, signal peptide removed glycosylated form | FST/iso:1/SigPep-/GlycoRes+ |
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000000434 follistatin isoform 1 cleaved and N-glycosylated 2 | FST/iso:1/ClvNGlyco:2 |
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036413 follistatin isoform 1 cleaved and N-glycosylated 2 (pig) | pig-FST/iso:1/ClvNGlyco:2 |
Yes |
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036414 follistatin isoform 1 cleaved and N-glycosylated 2 (human) | hFST/iso:1/ClvNGlyco:2 |
Yes |
|
|
|
|
|
| | | | | | |
| | | |
organism-modification
|
|
PR:000036412 follistatin isoform 1, signal peptide removed glycosylated form (human) | hFST/iso:1/SigPep-/GlycoRes+ |
Yes |
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036414 follistatin isoform 1 cleaved and N-glycosylated 2 (human) | hFST/iso:1/ClvNGlyco:2 |
Yes |
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000000280 follistatin isoform 2, signal peptide removed glycosylated form | FST/iso:2/SigPep-/GlycoRes+ |
|
|
|
|
|
|
| | | | | | |
| | | |
organism-modification
|
|
PR:000036415 follistatin isoform 2, signal peptide removed N-glycosylated 1 (human) | hFST/iso:2/SigPep-/NGlyco:1 |
Yes |
|
|
|
|
|
| | | | | | |
| | | |
organism-modification
|
|
PR:000036416 follistatin isoform 2, signal peptide removed N-glycosylated 1 (pig) | pig-FST/iso:2/SigPep-/NGlyco:1 |
|
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000000414 activin receptor type-2A isoform 1 glycosylated and phosphorylated form | ACVR2A/iso:1/GlycoPhos+ |
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000000528 activin receptor type-2A isoform 1 glycosylated and phosphorylated 1 | ACVR2A/iso:1/GlycoPhos:1 |
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036440 activin receptor type-2A isoform 1 glycosylated and phosphorylated 1 (mouse) | mACVR2A/iso:1/GlycoPhos:1 |
Yes |
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036441 activin receptor type-2A isoform 1 glycosylated and phosphorylated 1 (human) | hACVR2A/iso:1/GlycoPhos:1 |
Yes |
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000000415 activin receptor type-2B isoform ActR-IIB2 glycosylated and phosphorylated form | ACVR2B/iso:ActR-IIB2/GlycoPhos+ |
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000000529 activin receptor type-2B isoform ActR-IIB2 N-glycosylated and phosphorylated 1 | ACVR2B/iso:ActR-IIB2/NGlycoPhos:1 |
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036442 activin receptor type-2B isoform ActR-IIB2 N-glycosylated and phosphorylated 1 (mouse) | mACVR2B/iso:ActR-IIB2/NGlycoPhos:1 |
Yes |
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036443 activin receptor type-2B isoform ActR-IIB2 N-glycosylated and phosphorylated 1 (human) | hACVR2B/iso:ActR-IIB2/NGlycoPhos:1 |
Yes |
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000000419 Muellerian-inhibiting factor isoform 1 cleaved and glycosylated form | AMH/iso:1/ClvGlyco+ |
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000000534 Muellerian-inhibiting factor isoform 1 cleaved and glycosylated 2 | AMH/iso:1/ClvGlyco:2 |
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036444 Muellerian-inhibiting factor isoform 1 cleaved and N-glycosylated 2 (human) | hAMH/iso:1/ClvNGlyco:2 |
Yes |
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000000421 c-myc protein isoform 1 glycosylated form | MYC/iso:1/GlycoRes+ |
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000000536 c-myc protein isoform 1 O-glycosylated 1 | MYC/iso:1/OGlyco:1 |
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000026051 c-myc protein isoform 1 O-glycosylated 1 (human) | hMYC/iso:1/OGlyco:1 |
Yes |
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000000429 decorin isoform A cleaved and glycosylated form | DCN/iso:A/ClvGlyco+ |
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000000545 decorin isoform A cleaved and glycosylated 1 | DCN/iso:A/ClvGlyco:1 |
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036457 decorin isoform A cleaved and glycosylated 1 (human) | hDCN/iso:A/ClvGlyco:1 |
Yes |
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000000432 tumor necrosis factor ligand superfamily member 6 isoform FasL glycosylated form | FASLG/iso:FasL/GlycoRes+ |
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000000546 tumor necrosis factor ligand superfamily member 6 isoform FasL N-glycosylated 1 | FASLG/iso:FasL/NGlyco:1 |
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036458 tumor necrosis factor ligand superfamily member 6 isoform FasL N-glycosylated 1 (human) | hFASLG/iso:FasL/NGlyco:1 |
Yes |
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000000446 interferon gamma isoform 1, signal peptide removed glycosylated form | IFNG/iso:1/SigPep-/GlycoRes+ |
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000000447 interferon gamma isoform 1 cleaved and N-glycosylated 2 | IFNG/iso:1/ClvNGlyco:2 |
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036420 interferon gamma isoform 1 cleaved and N-glycosylated 2 (human) | hIFNG/iso:1/ClvNGlyco:2 |
Yes |
|
|
|
|
|
| | | | | | |
| | | |
organism-modification
|
|
PR:000036407 interferon gamma isoform 1, signal peptide removed glycosylated form (mouse) | mIFNG/iso:1/SigPep-/GlycoRes+ |
Yes |
|
|
|
|
|
| | | | | | |
| | | |
organism-modification
|
|
PR:000036419 interferon gamma isoform 1, signal peptide removed N-glycosylated 1 (human) | hIFNG/iso:1/SigPep-/NGlyco:1 |
Yes |
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000000485 thrombospondin-1 isoform 1 cleaved and glycosylated form | THBS1/iso:1/ClvGlyco+ |
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000000590 thrombospondin-1 isoform 1 cleaved 2 glycosylated form | THBS1/iso:1/Clv:2/GlycoRes+ |
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036489 thrombospondin-1 isoform 1 cleaved 2 glycosylated 1 (human) | hTHBS1/iso:1/Clv:2/Glyco:1 |
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036490 thrombospondin-1 isoform 1 cleaved 2 glycosylated form (mouse) | mTHBS1/iso:1/Clv:2/GlycoRes+ |
Yes |
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000000492 transcription factor Sp1 isoform 1 glycosylated form | SP1/iso:1/GlycoRes+ |
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000000598 transcription factor Sp1 isoform 1 O-glycosylated 1 | SP1/iso:1/OGlyco:1 |
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036498 transcription factor Sp1 isoform 1 O-glycosylated 1 (human) | hSP1/iso:1/OGlyco:1 |
Yes |
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000000505 bone morphogenetic protein 7 isoform 1, mature glycosylated form | BMP7/iso:1/ClvGlyco+ |
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000000613 bone morphogenetic protein 7 isoform 1, mature N-glycosylated 1 | BMP7/iso:1/mature/NGlyco:1 |
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036517 bone morphogenetic protein 7 isoform 1, mature N-glycosylated 1 (human) | hBMP7/iso:1/mature/NGlyco:1 |
Yes |
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036518 bone morphogenetic protein 7 isoform 1, mature N-glycosylated 1 (mouse) | mBMP7/iso:1/mature/NGlyco:1 |
Yes |
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000000614 bone morphogenetic protein 7 isoform 1, mature N-glycosylated 2 | BMP7/iso:1/mature/NGlyco:2 |
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036519 bone morphogenetic protein 7 isoform 1, mature N-glycosylated 2 (human) | hBMP7/iso:1/mature/NGlyco:2 |
Yes |
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000000935 potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 isoform 1 glycosylated form | HCN1/iso:1/GlycoRes+ |
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000000984 potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 isoform 1 N-glycosylated 1 | HCN1/iso:1/NGlyco:1 |
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036573 potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 isoform 1 N-glycosylated 1 (mouse) | mHCN1/iso:1/NGlyco:1 |
Yes |
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000000936 potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 isoform 1 glycosylated form | HCN2/iso:1/GlycoRes+ |
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000000985 potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 isoform 1 N-glycosylated 1 | HCN2/iso:1/NGlyco:1 |
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036574 potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 isoform 1 N-glycosylated 1 (mouse) | mHCN2/iso:1/NGlyco:1 |
Yes |
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000000989 voltage-gated potassium channel KCNH2 isoform A glycosylated form | KCNH2/iso:A/GlycoRes+ |
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000000998 voltage-gated potassium channel KCNH2 isoform A N-glycosylated 1 | KCNH2/iso:A/NGlyco:1 |
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036581 voltage-gated potassium channel KCNH2 isoform A N-glycosylated 1 (human) | hKCNH2/iso:A/NGlyco:1 |
Yes |
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036582 voltage-gated potassium channel KCNH2 isoform A N-glycosylated 1 (mouse) | mKCNH2/iso:A/NGlyco:1 |
Yes |
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000001048 cftr isoform 1 glycosylated form | CFTR/iso:1/GlycoRes+ |
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000001049 cftr isoform 1 N-glycosylated 1 | CFTR/iso:1/NGlyco:1 |
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036593 cftr isoform 1 N-glycosylated 1 (human) | hCFTR/iso:1/NGlyco:1 |
|
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000001723 transient receptor potential cation channel TRPM8 isoform 1 glycosylated form | TRPM8/iso:1/GlycoRes+ |
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000001724 transient receptor potential cation channel TRPM8 isoform 1 N-glycosylated 1 | TRPM8/iso:1/NGlyco:1 |
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036607 transient receptor potential cation channel TRPM8 isoform 1 N-glycosylated 1 (mouse) | mTRPM8/iso:1/NGlyco:1 |
|
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000001737 inhibin alpha chain isoform 1 glycosylated form | INHA/iso:1/GlycoRes+ |
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000001732 inhibin alpha chain isoform 1 cleaved and glycosylated form | INHA/iso:1/ClvGlyco+ |
|
|
|
|
|
|
| | | | | | | | |
| |
modification
|
|
PR:000001733 inhibin alpha chain isoform 1 cleaved and N-glycosylated 2 | INHA/iso:1/ClvNGlyco:2 |
|
|
|
|
|
|
| | | | | | | | | | |
organism-modification
|
|
PR:000036608 inhibin alpha chain isoform 1 cleaved and N-glycosylated 2 (human) | hINHA/iso:1/ClvNGlyco:2 |
Yes |
|
|
|
|
|
| | | | | | | | |
| |
modification
|
|
PR:000001736 inhibin alpha chain isoform 1 cleaved and N-glycosylated 1 | INHA/iso:1/ClvNGlyco:1 |
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000001738 inhibin alpha chain isoform 1 N-glycosylated 1 | INHA/iso:1/NGlyco:1 |
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036610 inhibin alpha chain isoform 1 N-glycosylated 1 (human) | hINHA/iso:1/NGlyco:1 |
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000001739 inhibin alpha chain isoform 1 N-glycosylated 2 | INHA/iso:1/NGlyco:2 |
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036611 inhibin alpha chain isoform 1 N-glycosylated 2 (human) | hINHA/iso:1/NGlyco:2 |
|
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000001792 prominin-1 isoform 6 glycosylated form | PROM1/iso:6/GlycoRes+ |
|
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000001793 prominin-1 isoform 3 glycosylated form | PROM1/iso:3/GlycoRes+ |
|
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000003018 prostate-specific antigen isoform 1 cleaved and glycosylated form | KLK3/iso:1/ClvGlyco+ |
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000003019 prostate-specific antigen isoform 1 cleaved and N-glycosylated 1 | KLK3/iso:1/ClvNGlyco:1 |
|
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000003081 neuropilin-1 isoform 1, signal peptide removed glycosylated form | NRP1/iso:1/SigPep-/GlycoRes+ |
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000003082 neuropilin-1 isoform 1, signal peptide removed O-glycosylated 1 | NRP1/iso:1/SigPep-/OGlyco:1 |
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036631 neuropilin-1 isoform 1, signal peptide removed O-glycosylated 1 (human) | hNRP1/iso:1/ClvOGlyco:1 |
Yes |
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000003083 neuropilin-1 isoform 1, signal peptide removed O-glycosylated 2 | NRP1/iso:1/SigPep-/OGlyco:2 |
|
|
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000036632 neuropilin-1 isoform 1, signal peptide removed O-glycosylated 2 (human) | hNRP1/iso:1/ClvOGlyco:2 |
Yes |
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000003227 HIV envelope glycoprotein gp160 glycosylated form | env/Clv:gp160/GlycoRes+ |
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000003229 HIV envelope glycoprotein gp120 glycosylated form | env/Clv:gp120/GlycoRes+ |
|
|
|
|
|
|
| | | | | | | | |
| |
modification
|
|
PR:000036935 HIV envelope glycoprotein gp120 N-glycosylated 1 | env/Clv:gp120/NGlyco:1 |
|
|
|
|
|
|
| | | | | | | | | | |
organism-modification
|
|
PR:000036640 envelope glycoprotein gp120 glycosylated 1 (Human immunodeficiency virus type 1 group M subtype B (isolate ARV2/SF2)) | env/Clv:gp120/NGlyco:1 (HV1A2) |
|
|
|
|
|
|
| | | | | | | | | | |
organism-modification
|
|
PR:000044791 envelope glycoprotein gp120 N-glycosylated 1 (Human immunodeficiency virus type 1 group M subtype B (isolate JRCSF)) | HIV1(JRCSF)-env/Clv:gp120/NGlyco:1 |
Yes |
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000003230 HIV envelope glycoprotein gp41 glycosylated form | env/Clv:gp41/GlycoRes+ |
|
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000003255 antithrombin-III isoform 1, signal peptide removed glycosylated form | SERPINC1/iso:1/SigPep-/GlycoRes+ |
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000003256 antithrombin-III isoform 1, signal peptide removed glycosylated 1 | SERPINC1/iso:1/SigPep-/Glyco:1 |
|
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000003298 lymphocyte antigen 96 isoform 1, signal peptide removed glycosylated form | LY96/iso:1/SigPep-/GlycoRes+ |
| Yes |
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000003299 lymphocyte antigen 96 isoform 1, signal peptide removed N-glycosylated 1 | LY96/iso:1/SigPep-/NGlyco:1 |
| Yes |
|
|
|
|
| | | | | | | | |
| |
organism-modification
|
|
PR:000025786 lymphocyte antigen 96 isoform 1, signal peptide removed N-glycosylated 1 (human) | hLY96/iso:1/SigPep-/NGlyco:1 |
Yes | Yes |
|
|
|
|
| | | | | | |
| | | |
organism-modification
|
|
PR:000027171 lymphocyte antigen 96 isoform 1, signal peptide removed N-glycosylated 1 (mouse) | mLY96/iso:1/SigPep-/NGlyco:1 |
Yes | Yes |
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000021989 leucoagglutinating phytohemagglutinin isoform 1, signal peptide removed glycosylated form | DLEC2/iso:1/SigPep-/GlycoRes+ |
|
|
|
|
|
|
| | | | | | |
| | | |
modification
|
|
PR:000021957 leucoagglutinating phytohemagglutinin isoform 1, signal peptide removed N-glycosylated 1 | DLEC2/iso:1/SigPep-/NGlyco:1 |
|
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000025408 T-cell surface glycoprotein CD8 alpha chain isoform 1, signal peptide removed glycosylated form | CD8A/iso:1/SigPep-/GlycoRes+ |
| Yes |
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000025409 T-cell surface glycoprotein CD8 beta chain isoform 1, signal peptide removed glycosylated form | CD8B/iso:1/SigPep-/GlycoRes+ |
| Yes |
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000025813 receptor-type tyrosine-protein phosphatase C isoform CD45RABC, signal peptide removed glycosylated form | PTPRC/iso:CD45R/SigPep-/GlycoRes+ |
|
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000025814 receptor-type tyrosine-protein phosphatase C isoform CD45RA, signal peptide removed glycosylated form | PTPRC/iso:CD45RA/SigPep-/GlycoRes+ |
|
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000025815 receptor-type tyrosine-protein phosphatase C isoform CD45RB, signal peptide removed glycosylated form | PTPRC/iso:CD45RB/SigPep-/GlycoRes+ |
|
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000025816 receptor-type tyrosine-protein phosphatase C isoform CD45RO, signal peptide removed glycosylated form | PTPRC/iso:CD45RO/SigPep-/GlycoRes+ |
|
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000025817 receptor-type tyrosine-protein phosphatase C isoform CD45RC, signal peptide removed glycosylated form | PTPRC/iso:CD45RC/SigPep-/GlycoRes+ |
|
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000025818 receptor-type tyrosine-protein phosphatase C isoform CD45RAB, signal peptide removed glycosylated form | PTPRC/iso:CD45RAB/SigPep-/GlycoRes+ |
|
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000025819 receptor-type tyrosine-protein phosphatase C isoform CD45RAC, signal peptide removed glycosylated form | PTPRC/iso:CD45RAC/SigPep-/GlycoRes+ |
|
|
|
|
|
|
| | | | |
| | | | | |
modification
|
|
PR:000025820 receptor-type tyrosine-protein phosphatase C isoform CD45RBC, signal peptide removed glycosylated form | PTPRC/iso:CD45RBC/SigPep-/GlycoRes+ |
|
|
|
|
|
|
| | | | |
| | | | | |
organism-modification
|
|
PR:000037264 cochlin, signal peptide removed glycosylated form (mouse) | mCOCH/SigPep-/GlycoRes+ |
|
|
|
|
|
|
|
| | | | |
| | | | | |
organism-modification
|
|
PR:000044792 interleukin-1 receptor-like 1 isoform B, signal peptide removed glycosylated form (mouse) | mIL1RL1/iso:B/SigPep-/GlycoRes+ |
|
|
|
|